A California supplier of abortion pills is making arrangements for an alternative plan in response to potential Supreme Court limitations on mifepristone, as the justices deliberate on the drug’s legality.
While the Supreme Court hasn’t announced when it’ll make a final decision in the case of Louisiana v. FDA, there’s a looming deadline of May 11. This date signifies the end of a current pause on lower court rulings unless the justices intervene.
The recent ruling from the Fifth Circuit has reinstated an older requirement, mandating that mifepristone be dispensed in person. This effectively halts telemedicine prescriptions and the widespread mailing of the medication. In light of this, Justice Samuel Alito has temporarily blocked the ruling from taking effect as the Supreme Court considers its options.
Mifepristone is involved in about two-thirds of abortions across the United States. Amidst this legal uncertainty, California suppliers are taking steps to adapt and pivot their practices.
Dr. Michele Gomez, co-founder of the MYA Network—an organization focused on normalizing abortion care—mentioned that California’s supply chain is ready to switch to other abortion medications remarkably quickly. “It’s not going to go away and it’s not going to slow down,” she noted regarding abortion access.
Misoprostol is central to the supply chain and is often used together with mifepristone in most abortions in the U.S. However, some health experts believe that using misoprostol by itself is less effective and may lead to a higher incidence of side effects.
“Mifepristone and misoprostol are more effective and have fewer side effects than misoprostol alone,” reports the World Health Organization.
Despite the increased risks, suppliers are prepared to dispatch alternative medications if necessary. Gomez cited a prompt response following recent developments: “We heard about this on Friday, and on Saturday we heard from an organization that mail pill companies were mailing misoprostol,” she recounted, emphasizing their swift readiness.
On May 1, the Fifth Circuit ruled in favor of Louisiana, asserting that the FDA exceeded its authority by permitting abortion pills to be mailed between states where they are legal and those where they are not. Alito has granted a temporary stay on the ruling, but this suspension is set to expire on May 11.
